Financial Advisory Group trimmed its position in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) by 3.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,248 shares of the company’s stock after selling 138 shares during the period. […]